Suppr超能文献

普萘洛尔治疗后静脉血、动脉血和动脉化静脉血氨水平及其与肝性脑病的关系。

Venous, arterial, and arterialized-venous blood ammonia levels and their relationship to hepatic encephalopathy after propranolol.

作者信息

Snady H, Lieber C S

机构信息

Section of Liver Disease and Nutrition, Veterans Administration Medical Center, Bronx, New York.

出版信息

Am J Gastroenterol. 1988 Mar;83(3):249-55.

PMID:3344727
Abstract

To assess side effects of propranolol in the treatment of portal hypertension, we measured blood ammonia in 14 cirrhotics before and after administration of propranolol, and in six cirrhotics before and after placebo. We evaluated ammonia blood levels obtained from three sites: venous, arterial, and arterialized-venous, obtained by warming the forearm. Ammonia concentration of arterial and arterialized-venous blood were abnormal for all cirrhotics studied and significantly greater than the ammonia concentration of venous blood (p less than 0.01). When propranolol was administered to patients with alcoholic cirrhosis and marginal liver function, as reflected by ammonia levels above 60 microM, it caused a significant increase in ammonia levels in arterialized-venous and arterial, but not in venous, blood (p less than 0.05). Propranolol caused a significant increase in the time required to perform sensitive psychometric tests (p less than 0.05). Encephalopathy usually became clinically apparent when the mean of the arterial and arterialized-venous blood ammonia levels rose above 122 microM.

摘要

为评估普萘洛尔治疗门静脉高压症的副作用,我们测定了14例肝硬化患者服用普萘洛尔前后以及6例肝硬化患者服用安慰剂前后的血氨水平。我们评估了从三个部位获取的血氨水平:静脉血、动脉血以及通过加热前臂获得的动脉化静脉血。所有研究的肝硬化患者的动脉血和动脉化静脉血氨浓度均异常,且显著高于静脉血氨浓度(p<0.01)。当给酒精性肝硬化且肝功能处于边缘状态(以血氨水平高于60微摩尔/升为指标)的患者服用普萘洛尔时,动脉化静脉血和动脉血中的氨水平显著升高,但静脉血中的氨水平未升高(p<0.05)。普萘洛尔导致进行敏感心理测量测试所需时间显著增加(p<0.05)。当动脉血和动脉化静脉血氨水平的平均值升至高于122微摩尔/升时,脑病通常会在临床上显现出来。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验